Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.

Leite MI, Jones M, Ströbel P, Marx A, Gold R, Niks E, Verschuuren JJ, Berrih-Aknin S, Scaravilli F, Canelhas A, Morgan BP, Vincent A, Willcox N.

Am J Pathol. 2007 Sep;171(3):893-905.

2.

Frequency of seronegativity in adult-acquired generalized myasthenia gravis.

Chan KH, Lachance DH, Harper CM, Lennon VA.

Muscle Nerve. 2007 Nov;36(5):651-8.

PMID:
17654558
3.

Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.

Farrugia ME, Bonifati DM, Clover L, Cossins J, Beeson D, Vincent A.

J Neuroimmunol. 2007 Apr;185(1-2):136-44.

PMID:
17335909
4.

Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.

Cossins J, Burke G, Maxwell S, Spearman H, Man S, Kuks J, Vincent A, Palace J, Fuhrer C, Beeson D.

Brain. 2006 Oct;129(Pt 10):2773-83.

PMID:
16945936
5.

Dok-7 mutations underlie a neuromuscular junction synaptopathy.

Beeson D, Higuchi O, Palace J, Cossins J, Spearman H, Maxwell S, Newsom-Davis J, Burke G, Fawcett P, Motomura M, Müller JS, Lochmüller H, Slater C, Vincent A, Yamanashi Y.

Science. 2006 Sep 29;313(5795):1975-8.

6.

The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.

Okada K, Inoue A, Okada M, Murata Y, Kakuta S, Jigami T, Kubo S, Shiraishi H, Eguchi K, Motomura M, Akiyama T, Iwakura Y, Higuchi O, Yamanashi Y.

Science. 2006 Jun 23;312(5781):1802-5.

7.
8.

Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.

Losen M, Stassen MH, Martínez-Martínez P, Machiels BM, Duimel H, Frederik P, Veldman H, Wokke JH, Spaans F, Vincent A, De Baets MH.

Brain. 2005 Oct;128(Pt 10):2327-37.

PMID:
16150851
9.

The features of myasthenia gravis with autoantibodies to MuSK.

Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V, Trikic R, Djukic P, Apostolski S.

J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1099-102.

10.

Seronegative myasthenia gravis: disease severity and prognosis.

Romi F, Aarli JA, Gilhus NE.

Eur J Neurol. 2005 Jun;12(6):413-8.

PMID:
15885043
11.

Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation.

Spreadbury I, Kishore U, Beeson D, Vincent A.

J Neuroimmunol. 2005 May;162(1-2):149-56.

PMID:
15833370
12.

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.

Leite MI, Ströbel P, Jones M, Micklem K, Moritz R, Gold R, Niks EH, Berrih-Aknin S, Scaravilli F, Canelhas A, Marx A, Newsom-Davis J, Willcox N, Vincent A.

Ann Neurol. 2005 Mar;57(3):444-8.

PMID:
15732104
13.

Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.

Lauriola L, Ranelletti F, Maggiano N, Guerriero M, Punzi C, Marsili F, Bartoccioni E, Evoli A.

Neurology. 2005 Feb 8;64(3):536-8.

PMID:
15699390
14.

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.

Shiraishi H, Motomura M, Yoshimura T, Fukudome T, Fukuda T, Nakao Y, Tsujihata M, Vincent A, Eguchi K.

Ann Neurol. 2005 Feb;57(2):289-93.

PMID:
15668981
15.

Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.

Zhou L, McConville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, Drachman DB.

Muscle Nerve. 2004 Jul;30(1):55-60.

PMID:
15221879
16.

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.

McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, Vincent A.

Ann Neurol. 2004 Apr;55(4):580-4.

PMID:
15048899
17.

Clinical aspects of MuSK antibody positive seronegative MG.

Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A.

Neurology. 2003 Jun 24;60(12):1978-80.

PMID:
12821744
18.

Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.

Brain. 2003 Oct;126(Pt 10):2304-11.

PMID:
12821509
19.

AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.

Plested CP, Tang T, Spreadbury I, Littleton ET, Kishore U, Vincent A.

Neurology. 2002 Dec 10;59(11):1682-8.

PMID:
12473752
20.

Unravelling the pathogenesis of myasthenia gravis.

Vincent A.

Nat Rev Immunol. 2002 Oct;2(10):797-804. Review.

PMID:
12360217

Supplemental Content

Support Center